NASDAQ
Intellia Therapeutics, Inc. (NTLA) has a fcf yield of -36.40% as of Friday, May 29, 2026. This represents a 130.14% decrease compared to its 12-month average of -15.82%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.